Combination treatment reduces risk of tumor progression in aggressive form of breast cancer, study shows Use of Gilead’s Trodelvy, Merck’s Keytruda together could change practice, experts say ...

Liebherr refrigerators and freezers introduces new combination refrigerator-freezer expanding current scientific and healthcare portfolio to meet the needs of healthcare, biotechnology and pharma ...

Liebherr expands scientific portfolio with new combination refrigerator-freezer for research and laboratory needs By Liebherr Appliances USA May 23, 2025 Updated May 23, 2025 1 of 2 ...

The developers of OpenPGP.js have released updates to patch a critical vulnerability that can be exploited to spoof message signature verification. OpenPGP.js is an open source JavaScript ...

The issue has been addressed in versions 4.2.5 and 2.14.3. xrpl.js is a popular JavaScript API for interacting with the XRP Ledger blockchain, also called the Ripple Protocol, a cryptocurrency ...

More than two thirds of lung tumors are diagnosed at the metastatic stage, making them inoperable. Despite the poor prognosis, the average 5-year survival rate has doubled from 10% to 20% over the ...

In immune-mediated inflammatory diseases, the overall risk for serious adverse events is not notably higher with combo therapy than with monotherapy, though some combinations may pose increased risk.

Alpine.js is a front-end JavaScript framework fashioned like a lightweight backpack, with a minimalist API and thoughtful features. Let's give it a try. I recently backpacked through Big Sur, and ...

Repository files navigation Week 6 JavaScript Lab Each of the "days" of this lab are in their own folder. Each folder contains three files: index.html, event-listners.js, and script.js. You will only ...

A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

The efficacy and tolerability of the 2-drug regimen of dolutegravir (DTG) and lamivudine (3TC) in individuals living with HIV was evaluated in a review published in Infectious Diseases and Therapy ...